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Abstract 
Objective: To develop a pharmacist-led osteoporosis screening intervention based on 
interviews with stakeholders. 
Methods: Nurses(n=10), pharmacists(n=11), doctors(n=10), patients(n=20) and policy 
makers(n=5) from a primary care clinic in Malaysia, were individually interviewed using a 
semi-structured topic guide. Purposive sampling was used to ensure a maximum variation 
sample. Interviews were transcribed verbatim and analysed using thematic analysis. The 
themes which emerged within each group were similar and the analysis of all the 
stakeholders were combined. The behavioural change wheel (BCW) was used as it draws 
on relevant theories to guide the selection of interventions that are most likely to be effective.  
Results: Several barriers were identified: governmental, organisational, work environment, 
team, individual, tasks and patient factors. We decided to develop our intervention based on 
patient factors as these directly influence practice and outcomes.  The main patient factor 
was their nonchalant attitude towards osteoporosis, it was perceived to be a non-life 
threatening disease. Hence, our intervention consisted of: an assessment of patients’ 
osteoporosis risk by the pharmacist whilst the patients are waiting for the doctor’s 
appointment, an education session, and restructuring of the current practice which 
incorporates this intervention into daily clinic practice. Subsequently, a recommendation to 
the doctor was made for a bone mineral density scan when necessary.  
Conclusions: This is the first study to use the Behaviour Change Wheel study to develop an 
osteoporosis screening intervention. The BCW assisted the development of a pharmacist-led 
osteoporosis screening intervention. This intervention will be evaluated for its feasibility in a 
future study 
 
Keywords: osteoporosis, screening, pharmacist, behavioural change wheel, primary care, 
qualitative 
 
Introduction 
Osteoporosis is known as the ‘silent disease’ due to its asymptomatic nature. The end result 
of osteoporosis is a fragility fracture (1). A fragility fracture is a low trauma fracture or a 
fracture that would not have normally occurred at a standing height. Due to the disease’s 
asymptomatic nature, patients who have osteoporosis may not know they have osteoporosis 
until a fracture has occurred. These fragility fractures are debilitating to both the patient and 
the economy (1, 2). 
Consequences, to the patient includes increase morbidity and mortality (1). A common site 
for fragility fracture is at the hip and is considered the most serious osteoporosis fracture, 
most probably necessitates hospitalization (1).  Studies have shown that up to 20% of 
patients die in the first year following a hip fracture and less than half of survivors regain the 
level of function that they had prior to the hip fracture (3, 4). It has been found that the 
mortality, morbidity and social burden of hip fractures in Asian countries are similar to those 
in the West. A Singaporean study has found that after a hip fracture, 20% of patients will die 
within two years, 33% remain ambulant without aids, 40% are ambulant with aids, and 10% 
are wheel chair or bed bound (1, 5).  
Economically, the disability caused by osteoporosis is comparable or greater than that lost to 
a variety of chronic non-communicable diseases, such as rheumatoid arthritis, asthma and 
high blood pressure related heart disease (6). For example, the cost of osteoporosis, 
including pharmacological intervention in the EU in 2010 was estimated at €37 billion. This 
includes the costs of treating incident fractures represented 66%, pharmacological 
prevention 5% and long-term fracture care 29% (7, 8) . The direct hospitalisation cost for hip 
fractures in Malaysia from year 1997 was estimated at RM22 million (~$6000 000). This is 
an underestimate as it does not include the cost incurred in rehabilitation and long term 
nursing care Therefore, without proper intervention the cost will escalate as the population 
ages (9). 
Although treatment for osteoporosis are available, cost effective, well-tolerated and effective 
to reduce fracture risk, only approximately 20 percent of women who have an osteoporosis-
related fracture receive either a bone mineral density test or a prescription for a drug to treat 
osteoporosis in the six months after the fracture (10-12). Studies have found that early 
detection of osteoporosis (screening and prevention) is the most cost-effective ways to 
reduce the number of hospital admittance due to osteoporotic fractures. (13, 14, 11, 15). 
Screening and prevention of osteoporosis can be divided to primary and secondary. Primary 
prevention of osteoporosis is directed at identifying high risk non-osteoporotic individuals, 
while secondary prevention of osteoporosis refers to the early detection of the disease and 
prevention of subsequent fragility fracture. 
There has been much focus on secondary prevention due to the clarity of its cost 
effectiveness as compared to primary prevention. In year 2012, the International 
Osteoporosis Foundation (IOF) launched a campaign called ‘Capture the Fracture’ (16, 17). 
The aim of this campaign was to reduce the incidence of secondary fractures throughout the 
world by the establishment of a new standard of care for fragility fracture sufferers. 
Healthcare providers were urged to respond to the first fracture to prevent the second and 
subsequent fractures. It has been found that the most effective way to achieve this is 
through the implementation of coordinator-based, post fracture models of care. To date 
various model known as ‘Fracture Liaison Services’ have been conducted in the United 
Kingdom (18-22), Europe (23, 24) and Australia (25-27). In Canada these services are called 
‘Osteoporosis Coordinator Programmes’ (28) and in the US it is called the ‘Care Manager 
Programmes’ (29). Despite, the considerable progress made in terms of establishment of 
exemplar services in many countries (16, 17), these services are currently only available in a 
very small proportion of facilities that receive fracture patient worldwide. These services are 
also the beginning of inclusion of secondary fracture prevention in national health policy (30-
32). However, many governments  are yet to create the political framework to support 
funding of these new services. Additionally these services only target the population who 
have had a previous history of fractures.  Currently, there is no osteoporosis screening 
programme or fracture liaison services available in Malaysia.  
There is a growing body of literature supporting the roles of pharmacists in osteoporosis 
(33). Studies conducted in various settings around the globe have shown those pharmacists’ 
interventions improved adherence to osteoporosis medication. Some studies have also 
reported improvements in both clinical and economic outcome (34-37). Although, most 
pharmaceutical care services are mainly targeted at treatment of osteoporosis. A further 
literature search revealed that there are three randomized control trials (RCTs) conducted by 
community pharmacies in Canada, Australia and US to evaluate the impact of pharmacist’s 
interventions on osteoporosis management (38-40). However, two of these studies were 
considered biased (41). Nonetheless, all three studies provided attestation that the 
intervention of pharmacists increased the number of patients that had their BMD tested and 
calcium intake initiated, indicating that pharmacists may have a role to play in reducing the 
gap in osteoporosis management (38-40). To date, there is no osteoporosis screening 
program in Malaysia. Therefore, this study aims to develop a pharmacist-led osteoporosis 
screening program in Malaysia using the behavioural change wheel. This is also a follow up 
study of the previously published paper on interprofessional-collaboration in osteoporosis 
screening (33). 
 
Methods 
Design 
This was a qualitative study using semi-structured in-depth interviews as it allowed us to 
explore the barriers and suitable interventions for developing a pharmacist-led osteoporosis 
screening program. The United Kingdom Medical Research Council (UKMRC) framework for 
complex intervention was used to guide the process of developing the intervention (42). The 
behavioural change wheel was the theory used to guide the development of the intervention 
within the screening program. Ethics approval was obtained from, the University Malaya 
Medical Centre Ethics Committee (approval number 914.14) 
Setting 
This study was conducted at the primary care clinics of University Malaya Medical Centre 
(UMMC), Kuala Lumpur, Malaysia. 
 
  
Participants and sampling 
Patients 
Non-osteoporosis postmenopausal women ≥ 50 years of age from the three main ethnic 
groups (the Malays, Chinese and Indian) in Malaysian was selected using purposive 
sampling. Exclusion were those not healthy to participate in the study. 
Nurses 
Purposive sampling was used to select nurses from the primary care with more than one 
year of working experience in the primary care clinic. Nurses with at least one year of 
working experience at the primary care was selected to ensure that they had sufficient 
working experience and understanding of the primary care clinic’s processes. Nurses were 
included in the study as they were involved in patient registration, screening and their 
medical records. They provided information on the clinic’s general workflow. Excluded were 
nurses from other departments. 
Doctors 
Similarly, doctors with more than one year of working experience from the primary care clinic 
were selected via purposive sampling. The doctors were included in the study as they were 
involved with examining the patients.  
Pharmacists 
Purposive sampling was also used to select pharmacists. The pharmacists recruited had at 
least one year of working experience in the outpatient pharmacy. Intern pharmacists were 
excluded as they were not in a position to make any decisions regarding pharmacy practice. 
We included pharmacists in our study as we wanted to explore the expansion of the 
pharmacists’ role to include osteoporosis screening.  
Policy makers 
The definition used for policy makers in this study was individuals who had the authority to 
influence practice. The Head of Primary Care Department was included as her view 
represented the management of primary care doctors. The Heads of outpatient pharmacy, 
pharmacy store, in-patient pharmacy, as well as the chief pharmacists were also included 
due to their involvement in the development and administration of pharmacy services. 
However, there were three policy makers who did not respond to the invitation to participate 
in this study: the head of nursing, the Chief Executive Offier (CEO) and the deputy CEO.  
 
Instrument used 
Baseline demographic form 
We collected the patients’ medical history, lifestyle and medication history using the baseline 
demographic form. A different form was used to collect information from the healthcare 
professionals (nurses, doctors, pharmacists and policy makers) regarding their work 
experience and level of education. 
 
Topic guide 
Three separate topic guides were developed: one for patients, one for healthcare 
professionals (nurses, pharmacists, doctors) and one for policy makers. These topic guides 
explored the stakeholder’s knowledge, feelings and attitudes towards developing a 
pharmacist-led osteoporosis-screening program. Literature review and expert panel 
(consisting of a consultant endocrinologist and four pharmacists with many years of research 
and clinical experience) discussion were used to develop the topic guide. The topic guide 
was finalised via a pilot with three individuals (one for each topic guide). 
As some interviews were anticipated to be conducted in Malay, the topic guide for patients 
and healthcare professionals (nurses, pharmacists, doctor) was translated to Malay. A 
pharmacist who was a native Malay speaker performed the forward translation of the topic 
guide from English to Malay. Back translation (from Malay to English) was then performed by 
another pharmacist who was bilingual in both English and Malay. The pharmacists involved 
in the translation were not participants of this study. An expert panel was used to discuss the 
differences to finalize the Malay version of the topic guide. 
 
Procedure 
Patients were purposively selected to ensure maximum variation. The patients were 
recruited by the researcher who approached them personally while there were waiting for 
their doctor’s appointment. The researcher screened the medical records to confirm that the 
patients recruited did not have osteoporosis/osteopenia. A printed participant information 
sheet was used to explain the purpose of the study to the participants. Written consent was 
obtained upon agreement and the baseline demographics data form was filled. 
The interviews with the patients commenced from October 2012 to January 2013. The 
interviews were conducted in quiet location (e.g. conference room, seminar room or an 
unused doctor’s room) that was suitable for an interview within the clinic setting or at their 
homes. Although there were various locations used for the interview, they were all 
conducted in an environment that was quiet and private. As such, is it believed that the 
change in the settings would not have an impact on the quality of the interview itself (and the 
results). 
All interviews were conducted in either English of Malay by a trained researcher. The 
average interview length was 60 minutes. Interviews were transcribed verbatim. The 
researcher transcribed the first ten interviews. Undergraduate science students or 
pharmacist transcribed subsequent interviews. The rigour and trustworthiness of the 
transcriptions conducted by the research was ensured by allowing another pharmacist who 
was fluent in both languages to check it. The transcripts performed by the other transcribers 
were checked by the researcher for accuracy and completeness. All transcript were offered 
to all interviewees to check for accuracy but all declined. 
 
Data analysis 
Nvivo version 10 for Window, 2012, QSR International Pty Lt was used to manage the data. 
Memos were written at the end of each interview to capture interesting topic raised in the 
interview.  
In our study, each stakeholder was analysed separately: patients, pharmacists, nurses, 
doctors and policy makers were conducted separately. However, the themes which emerged 
within each group were similar and the analysis of all the stakeholders were combined. A 
subset of transcripts were reviewed by two other members of the research team for 
agreement of the codes and themes (LPSM and CA). Data analysis was divided into two 
phases (data driven and theory driven) to ensure analytical rigor. 
Firstly, the data driven analysis was conducted where codes were generated inductively (43, 
44). The data driven approach was used to minimize bias when the codes and themes were 
identified. The coding framework was developed using the identified nosed to code 
subsequent data. This was conducted by analysing each line of the transcript. The whole 
process was iterative and involved rereading, linking and connecting text to the nodes. A 
second researcher reviewed the codes and discrepancies were resolved. Next, the codes 
were then refocused at a widerr level of themes. The ‘one sheet of paper’ (OSOP) analysis 
as described by Ziebland and McPherson (2006) was used. The OSOP involved reading 
through each code and then noting all the themes on a piece of paper and making 
connections between them  (45).  The method allowed for the identification of deviant cases 
that did not fit into the emerging story. The deviant cases were then reanalysed and 
accounted for in the analysis. Data saturation was reached when no new codes emerged 
when new participants were recruited into the study.  
Theory driven approach was employed after the data driven analyisis. The analysis was 
enriched by going back to the literature noting how other research and theories fitted and 
how it could further enhance the information from the analysis. Additional codes were added 
if necessary (43, 44). The reason for using this approach is to confirm the themes identified 
by the data driven approach. The theory applied to our analysis was the behavioural change 
wheel. The behaviour change wheel (BCW) theory was utilized, as we wanted to develop an 
intervention to improve implementation of evidence-based health care. The changing of 
behaviour of the healthcare professionals, policy makers and others working within and with 
the healthcare system can improve the implementation of a complex intervention such as the 
osteoporosis screening programme.  The BCW is a framework for analyzing target 
behaviours in the context of the setting and considering the full range of intervention 
functions and policy categories that may be relevant to the intervention problems [Figure 1] 
(46) 
 
Figure 1: The behaviour change wheel (46) 
 
 The BCW was developed to provide a basis for identifying what it would take to achieve the 
desired behaviour change in terms of changes to capability, opportunity and motivation. This 
was called the COM-B system, which made up the core of the BCW [Figure 2] 
 
Figure 2: The COM-B system- a framework for understanding behaviour (46) 
 
 
The definition of capabilities is an individual’s psychological and physical capacity to engage 
in the activity concerned. It includes having the necessary knowledge and skills. As for 
opportunity, it is defined as all factors that lie outside the individual that make the behaviour 
possible or prompt it. There were two types, physical opportunity and social opportunity. 
Motivation is further distinguished from the reflective processes (involving evaluations and 
plans) and automatic processes (involving emotions and impulses that arise from associative 
learning and/or innate disposition). In Figure 2, the double arrows represent potential 
influence between the components of the system.  
The COM-B model then links this to nine intervention functions in the BCW (education, 
persuasion, incentivisation, coercion, training, restriction, environmental restructuring, 
modelling and enablement) and seven types of policy that could be used to implement these 
intervention functions (mass-media/marketing legislation, fiscal policy, service provision, 
guideline development, regulation and environmental/social planning). It forms the basis of a 
systematic analysis of how to make the selection of intervention and policies. Therefore, this 
assists in selecting the intervention function or functions most likely to be effective in 
changing the target behaviour.  
The intervention strategy can then be provisionally established and specific types of 
behaviour change technique can be selected, guided by evidence, theory and practicalities 
to deliver the intervention. We then need to select the type of behaviour change technique 
(BCT) with the guidance of the intervention function. Michie et al (2013) developed a 
taxonomy of 93 behaviours changed techniques on 16 clusters. We then selected the 
appropriate BCT based on the intervention function (47).  
The authors recommend to start by understanding the problem, identifying key specific 
behaviours (often several) by asking questions of who needs to do what differently, when, 
where and how. Behavioural change can occur at different levels in healthcare such as with 
patients, with healthcare professional and at an organisational level. Next they 
recommended understanding the behaviours in the context whereby the COM-B model can 
be used to answer questions such as why the behaviours are as they are and what needs to 
change for the desired behaviour to occur (46). Subsequently the developers need to 
consider the full range of possible intervention using the behaviour change wheel to select 
broad categories of intervention type. Then identify specific behaviour change techniques 
that can be selected to achieve the behaviour change (46).  
The developers then need to decide on the mode of delivery which could be face-to-face 
(individually/group) or distance (population level using media or individually tailored such as 
phone calls). Additionally, when selecting an intervention, mode of delivery and policy 
categories, issues such as evidence of effectiveness, local relevance, practicability, 
affordability and acceptability (public, professional and political) should be considered. 
Figure 2.7 summarizes this process. This model is well tested and has been shown to be 
useful in evaluating the 2010 English government tobacco control strategy and the National 
Institute for Health and Care Excellence (NICE) obesity guideline. Therefore, we decided 
that this is the most suitable theory to use to develop the pharmacists-led osteoporosis 
screening programme (46).   
  
  
Figure 3: Summary of approach to developing behaviour change intervention 
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Results 
Fifty-six participants were interviewed patients=20, nurses=10, pharmacists=11, doctors=10 
and policymakers=5. The age of the patients interviewed were between 52-72 years, out of 
which six were Malay, six were Indians, and eight were Chinese. Healthcare professionals 
interviewed had two to four years of working experience.  
For our study, the intervention efforts were targeted at the patients. Based on the framework 
of factors influencing clinical practice, patient factors most directly influence the practice and 
outcome and the probability of an incident (48). The overall target behaviour was to increase 
the number of patients undergoing a bone mineral density scan.  
Table 1 displays the barriers from the patient factors, the target behaviours derived from the 
barriers followed by identification of the cause using the COM-B model. The BCW was then 
used to pick the intervention functions, specific behaviour change techniques and policy 
category. The barriers from the patient factors were obtained from previous qualitative data 
which in the time of writing this paper is not yet published.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 1: Intervention functions, behaviour change techniques and policy categories used to address the patient factors 
Patient factors Target behaviour Understanding of the 
behaviours based on 
the COM-B model 
Intervention function Behaviour change 
technique 
Policies category 
Condition (complexity and seriousness) Environmental/ social 
planning 
• Developing a 
practical and 
sustainable 
osteoporosis 
screening 
programme 
 
• Osteoporosis 
is perceived 
to be not 
serious 
 
• Patients to 
understand 
that untreated 
osteoporosis 
can be life 
threatening 
• Psychological 
capability 
• Reflective 
motivation 
 
• Education 
• Environmental 
restructuring 
 
Shaping knowledge 
• Provide 
information on 
consequences of 
untreated 
osteoporosis 
Antecedents 
• Restructuring the 
physical and 
social 
environment by 
implementing an 
osteoporosis 
screening 
Personality 
• Nonchalant 
attitude towards 
osteoporosis 
 
 
 
• Patients 
willing to 
conduct 
osteoporosis 
screening 
and 
prevention 
measures 
 
• Psychological 
capability 
• Automatic 
motivation 
 
 
• Education 
• Persuasion 
• Environmental 
restructuring 
 
Shaping knowledge 
• Provide 
information about 
osteoporosis 
Comparison of outcomes 
• Persuasive 
arguments on 
benefits of 
screening and 
prevention 
Antecedents 
• Restructuring the 
physical and 
social 
environment by 
implementing an 
osteoporosis 
screening 
 
• Unwilling to 
listen to the 
healthcare 
professionals 
advice 
• Patients to 
trust 
healthcare 
professionals 
• Social 
opportunity 
 
 
 
• Environmental 
restructuring 
 
 
Antecedents 
• Restructuring the 
physical and 
social 
environment by 
implementing an 
osteoporosis 
screening 
programme 
Knowledge 
• Lack of 
knowledge 
 
• Improve all 
aspects 
patients 
knowledge 
towards 
osteoporosis  
• Psychological 
capability 
• Education 
• Environmental 
restructuring 
 
Shaping knowledge 
• Provide 
information about 
osteoporosis 
Antecedents 
• Restructuring the 
physical and 
social 
environment by 
implementing an 
osteoporosis 
screening 
Communication 
• Language barrier • Create 
opportunities 
to 
communicate 
information 
regarding 
osteoporosis 
• Social 
opportunity 
• Physical 
opportunity 
• Environmental 
restructuring 
 
Antecedents 
• Restructuring the 
physical and 
social 
environment by 
implementing an 
osteoporosis 
screening 
Social factors 
• Financial 
constraints 
 
• Affordable 
osteoporosis 
screening 
and 
medications 
• Reflective 
motivation 
• Physical 
opportunity 
• Environmental 
restructuring 
• Enablement  
Antecedents 
• Restructuring 
the physical 
and social 
environment 
by 
implementing 
an 
osteoporosis 
screening 
Social support 
• Social 
support 
(financial) 
 
• Time constraints 
 
• Ensure the 
osteoporosis 
screening 
programme is 
• Reflective 
motivation 
• Environmental 
restructuring 
• Enablement 
Social support 
• The 
osteoporosis 
screening 
conducted at 
a time 
convenient 
for the 
patients  
 
• Physical 
opportunity 
programme 
to be 
conducted at 
a practical 
time for the 
patients 
Antecedents 
• Restructuring 
the physical 
and social 
environment 
by 
implementing 
an 
osteoporosis 
screening 
• Short 
consultation time 
 
• Ensure 
sufficient time 
for 
consultation 
regarding 
osteoporosis 
 
• Social 
opportunity 
• Physical 
opportunity 
• Environmental 
restructuring 
• Enablement 
Social support 
• Sufficient 
consultation 
time 
Antecedents 
• Restructuring 
the physical 
and social 
environment 
by 
implementing 
an 
osteoporosis 
screening 
• Family 
circumstances 
Ensure that the 
osteoporosis 
screening programme 
• Physical 
opportunity 
• Environmental 
restructuring 
Social support 
• The 
osteoporosis 
is accessible to the 
patients 
• Enablement screening 
programme 
to be 
conducted at 
a practical 
time for the 
patients 
Antecedents 
• Restructuring 
the physical 
and social 
environment 
by 
implementing 
an 
osteoporosis 
screening 
 
 
 
 
Difficulty to adhere to osteoporosis prevention measure 
Difficulty to adhere to 
osteoporosis prevention 
measure 
• Ensure 
patients 
difficulty to 
adhere to 
osteoporosis 
prevention 
measure is 
addressed 
• Physical 
capability 
• Reflective 
motivation 
• Automatic 
motivation 
• Education 
• Enablement 
• Environmental 
restructuring 
 
Shaping knowledge 
• Provide 
instruction on 
how to perform 
preventive 
measures 
Goals and planning 
• Prompt barrier 
identification 
Antecedents 
• Restructuring 
the physical 
and social 
environment 
by 
implementing 
an 
osteoporosis 
screening 
 
 
 
 
 
 
 
 
 
 
Intervention function 1: Environment restructuring 
We addressed all the patient factors using the intervention function environmental 
restructuring via the BCT antecedents. Antecedents involved restructuring the physical and 
social environment of the primary care clinic by implementing a pharmacists-led 
osteoporosis screening programme. Restructuring of the physical environment of the primary 
care clinic refers to incorporating the programme as one of the clinic services. This 
restructures the social environment by allowing both patient and healthcare professionals to 
communicate regarding osteoporosis screening. The osteoporosis screening programme 
was tailored to execute various BCT directed at the patients’ factors which will be elaborated 
in sections below. 
Additionally, the BCT antecedent allows the healthcare professionals to address the issue of 
language barriers which are caused by the lack of physical and social opportunity (COM-B 
model). Physical opportunity refers to the lack of a physical opportunity for the patients to 
undergo osteoporosis screening. Social opportunity refers to the lack of opportunity for the 
patients to communicate with the healthcare professionals.  By conducting an osteoporosis 
screening programme, the health care professionals will be able to prepare the osteoporosis 
information in various languages and communicate with a larger population. The patients will 
have an opportunity to conduct osteoporosis screening. 
 
“... So (we) have to address (this)... larger ethnic groups, that are maybe Mandarin, or... 
English, then BM (Malay), Tamil (speaking)... So that... they can read and maybe they would 
understand, after that they can do something about it.”  
(DR-2/M/30y) 
 
Another barrier which was addressed by this BCT was the patients’ unwillingness to listen to 
the healthcare professionals’ advice. By conducting the osteoporosis screening programme, 
the healthcare professionals will be able to communicate with the patients more addressing 
the lack of social opportunity. Therefore, they can gain the patients’ trust by proving their 
capabilities and creating rapport with the patients, increasing their willingness to listen to 
advice. 
 
“... A bonding... So they will tell us all these things. So they will come.”    
         (DR-6/F/48y) 
 Intervention function 2: Education 
We found that other aspects of the patient factors: condition, knowledge, personality and 
difficulty to adhere to osteoporosis preventive measure can be addressed in more detail 
using an educational intervention via the BCT of shaping knowledge. Based on the COM-B 
model we evaluated that the patients’ lack of osteoporosis knowledge factor was affected by 
the lack in psychological capability. A lack of psychological capability in this case refers to 
the lack of osteoporosis knowledge. We aimed to improve all aspects of the patients’ 
osteoporosis knowledge.  
As for the patient factor condition, patients perceived osteoporosis as not to be serious 
condition. We evaluated it to be caused by the patients’ lack of psychological capability and 
reflective motivation from the COMB-B model. Due to the lack of knowledge on the 
consequences of untreated osteoporosis, patients evaluated osteoporosis to be a not 
serious condition.  This in turn affected the patients’ personality whereby they took a 
nonchalant attitude towards osteoporosis. We evaluated this issue to be due to the lack of 
psychological capability and automatic motivation from the COM-B model. As a lack of 
osteoporosis knowledge led to patients acting nonchalantly due to an innate dispositions 
such as perceiving osteoporosis to be not life threatening.  
Correspondingly, patients’ difficulties in adhering to osteoporosis preventive measures may 
be caused by a lack of psychological capability, physical capability, reflective motivation and 
automatic motivation. To elaborate on this, patients may have had difficulty to conduct 
weight-bearing exercises. Hence, it became an unpleasant activity as patients may feel pain 
leading to a reduction in motivation. Patients will then evaluate the preventive measures to 
be too difficult to adhere too. Educating patients will equip them with the knowledge on 
osteoporosis preventive measures suitable for their physical condition overcoming its 
difficulties. 
Therefore, based on stakeholders’ suggestions we developed a counselling session that was 
delivered by the pharmacist. Patients would receive 30 minutes of verbal counselling. Topics 
covered during the counselling session were the definition of osteoporosis, consequences of 
untreated osteoporosis, risk factors for osteoporosis, the role of the BMD scan (its function, 
what the results mean, accessibility and the frequency a patient has to go for a BMD scan), 
other tests used in osteoporosis screening [quantitative ultrasound scanning, x-ray, blood 
test and the Osteoporosis Self-assessment Tool for Asians (OSTA)], lifestyle changes 
(calcium intake, vitamin D intake, weight bearing exercise and fall prevention), and treatment 
of osteoporosis. Additionally particular emphasis was given to the consequences of 
untreated osteoporosis and how to conduct osteoporosis preventive measures.  
 
“I think you should counsel, counsel people because sometimes people are not aware of the 
importance of osteoporosis.”  
(PT-10/F/62y) 
 
Strategies to conduct the counselling session include using lay terms, pictorial descriptions 
and providing the patients with an osteoporosis booklet. Therefore during the counselling 
session an osteoporosis booklet was provided to the patients. This information booklet also 
allowed the pharmacists to engage the patients and assist the patients to visualize the 
information. Additionally, the patients were able to take the leaflet home with them and 
reread the information.  Please refer to Appendix 24 for the osteoporosis booklet.  
 
“(I need osteoporosis information) pamphlets, simple thing that we can understand. Not too 
scientific.” (PT-15/F/55y) 
 
Intervention function 3: Persuasion 
We used the intervention function persuasion to address the additional aspect of the 
patients’ nonchalant attitude caused by the automatic motivation.  This was achieved using 
the BCT whereby we compared the outcomes and use persuasive arguments on the 
benefits of osteoporosis screening and prevention specific to a patient. Stakeholders 
believed that an individualize counselling session would increase the effectiveness of the 
counselling session as it is easier for the patients to communicate as compared to a group 
counselling session. By individualizing the counselling sessions we can tailor the session 
based on the patients’ education background and address personal issues regarding 
osteoporosis screening and prevention.   
 
“If one to one session, I think they will... want to do it (osteoporosis preventive measure)... (it 
is) different... when we (compare with) dispens(ing) at the counter and (when) we talk to 
them personally. They will easily open up. They will tell us the problem.”    
   (PHARM-3/F/25y) 
Intervention function 4: Enablement 
Goals and planning: Prompt barrier identification 
Additionally, in order to address the aspect of reflective and automatic motivation from the 
factor ‘difficulty to adhere to preventive measures’. We used another intervention function 
called enablement where we used the BCT ‘prompt barrier identification when conducting an 
osteoporosis preventive measure.’ The pharmacist would discuss potential barriers (pain 
while exercising, funding, lactose intolerant etc) of conducting the osteoporosis preventive 
measure with the patients. This enables the pharmacists to tailor an osteoporosis preventive 
regimen suitable to the patient.  
 
“When patients... asks ‘Should I take calcium?’ ‘Should I take vitamin D?’… If you are 
wealthy enough, you want to take tablets, go ahead... If you are not so wealthy, you have... 
ten tablets to take… I would say enough. But if you can actually cope with your amount of 
medication... why not?” (PHARM-9/F/27y) 
 
Social support: Osteoporosis risk assessment tools 
We evaluated the financial constraints that were influenced by physical opportunity and 
reflective motivation. We addressed the lack of physical opportunity by using the intervention 
function enablement. The issue with the financial constraints is the cost of the BMD scan 
and medication. Therefore, we provided an osteoporosis risk assessment tool which screens 
for patients who are at high risk for osteoporosis. The risk assessment tool is a simple and 
quick calculation using the patients’ weight and age. This allows the hospitals resources 
such as the BMD scan and funding for the scans and medications to be used more 
effectively leading to more accessible osteoporosis screening for these patients. By giving 
the patients the opportunity to go for a free screening they will then evaluate that their 
finances can afford an osteoporosis scan thereby addressing the aspect of reflective 
motivation.  
 
“If it’s free... if you give me (a chance to go for osteoporosis screening). I don’t mind going.” 
  (PT-20/F/62y) 
 
Social support: The osteoporosis screening programme to be conducted at a 
practical time for the patients 
Similarly, the barrier of patients’ time constraints and family circumstances to attend the 
screening programme was affected by physical opportunity and reflective motivation. We 
addressed the lack of physical opportunity by using the intervention function enablement. 
Therefore, we decided to conduct the osteoporosis screening programme during the waiting 
time for the doctor’s appointment. The waiting can be one to three hours. By using this time 
frame we did not extend the patients’ time at the hospital nor did we need the patient to 
come to the hospital multiple times. This will hopefully lead to the patients positively 
evaluating the feasibility of going for the osteoporosis screening addressing the aspect of 
reflective motivation.  
 
“There should be (information and osteoporosis screening), maybe at the clinic while we 
(are) wait for the doctor (‘s) (appointment).” (PT-15/F/55y) 
 
Social support: Sufficient consultation time 
One of the patient factors was the lack of consultation time. We evaluated this to be caused 
by the lack of social opportunity and physical opportunity. Therefore by conducting a 
pharmacist-led osteoporosis screening programme during the waiting time for the doctor’s 
appointment we would have created an opportunity for the patients to discuss issue 
pertaining to osteoporosis. The pharmacists will be able to spend the time to communicate 
and address any issues that the patients may have. We allocated about 15-30 minutes per 
patients.  
 
“... The patient comes in, first (they) see the pharmacist, catch them, do the risk 
assessment... Just write in there (case notes) high risk, so the doctor is aware. Because we 
usually as doctors we don’t so much... time with the patient, with the work load especially. 
So it will be a good thing.” (DR-6/F/48y) 
 
 
 
Policy category 1: Environmental/social planning- Developing a practical and 
sustainable osteoporosis screening programme 
For our study the type of policies that can be used to implement the pharmacist osteoporosis 
screening programme is the policy category environmental/social planning. This involves 
designing and/or controlling the physical and social environment. Stakeholders emphasized 
that the planning of the programme was crucial. We needed to develop a practical, 
acceptable and sustainable osteoporosis programme. They suggested that in order for the 
programme to be a success upper management approval and support was essential.  
 
“That’s why must speak to the specialist, we must, make an appointment to go and see this 
osteoporosis specialist, talk to them, encourage them to have this type of campaign... Only 
these people who can start these campaigns.” (NUR-6/F/55y) 
 
The finalized intervention package 
Based on the BCW, our final intervention consisted of: an assessment of patients’ 
osteoporosis risk by the pharmacist whilst the patients are waiting for the doctor’s 
appointment (enablement), an education session (education), and restructuring of the 
current practice which incorporates this intervention into daily clinic practice (environmental 
restructuring). Subsequently, a recommendation to the doctor was made for a bone mineral 
density scan when necessary. The interventions were tailored to the individual patients as a 
face-to-face consultation (mode of delivery) as each patient has a different osteoporosis risk 
factors and osteoporosis knowledge level. 
 
Discussion 
Using the behavioural change wheel to address barriers from the patients’ factors we 
identified four key intervention components: environment restructuring, education, 
persuasion and enablement. This referred to the restructuring of the environment that was 
the need to develop and implement an osteoporosis screening programme by empowering 
the patient with osteoporosis knowledge. The programme should also be conducted one-on-
one with the patient to incorporate the persuasion aspect of the intervention and conducted 
a time convenient to patients without burdening the patients financially. All these key 
intervention components were used to develop an acceptable, practical and sustainable 
osteoporosis screening programme in a primary care clinic. 
 We compared the BCW to other approaches such as the Theory of Planned Behaviour and 
Health Belief Model (49, 50). We agreed with the BCW authors that both these theories do 
not address the important role of impulsivity, habit, self-control, associative learning and 
emotional processing. The BCW model includes automatic processing which broadens the 
understanding of behaviour beyond the reflective, systematic cognitive process that is 
normally focused of most behavioural research in implementation science and health 
psychology (46). These aspects have been considered in the BCW making it a 
comprehensive theory used for intervention design.    
Additionally, the behavioural change wheel may be incorporated into the context very 
naturally. By context we mean the ‘opportunity’ component of the model. This means that the 
behavioural can only be understood in relation to context making it a good starting point (46).  
The BCW was then compared to other frameworks such as MINDSPACE. MINDSPACE is a 
checklist for policymakers of the most important influences on behaviour from the UK’s 
Institute of Government (51). However this framework recognises two systems by which 
human behaviour can be influenced, the reflective and automatic. But it focused on the 
automatic part of the human behaviour and does not attempt to link influences on behaviour 
with these two systems making it incoherent. The BCW manages to link these two systems 
using the COM-B model (46).   
As for intervention mapping, a key difference between this and the BCW approach is that the 
intervention mapping aims to map behaviour on to its ‘theoretical determinants’ in order to 
identify potential levers for change (52). However the BCW approach recognises that the 
target behaviour system can in principle arise from combinations of any of the components 
of the behaviour system (46).  
A search of published literature found several randomized controlled trials (RCTs) for 
osteoporosis screening services. These RCTs were conducted by various healthcare 
professionals such as primary care physicians,(53, 54) orthopaedic surgeons, (55, 54) 
pharmacists (38-40) and nurses.(56). All of these interventions had similar components to 
our interventions in the sense that they all had an education component, osteoporosis risk 
assessment; the services were provided for free at a time convenient to the patients. 
However, the rationale for the intervention used was often unclear. Only four studies 
reported that the intervention was tailored to identified barriers (13, 53, 56, 57).  
Nonetheless, all interventions demonstrated a positive effect towards bone mineral density 
(BMD) scanning and osteoporosis treatment post fracture. (38, 53, 56, 39, 55, 54, 40).  
 Strengths of this study were that our intervention was informed by a theory. It has been 
hypothesised that interventions informed by psychological theory show greater efficacy than 
non-theory based studies. This is because theory driven interventions are more likely to 
target theoretically consistent or empirically supported mechanisms of behaviour change 
(58). However, interventions described as theory-based often have an unclear foundation 
(59). Although guidelines from the UK MRC framework for complex intervention advocates 
drawing on theory in intervention design, it does not specify how to select and apply 
theory(58). There is often no analysis undertaken to guide the choice of theories. Therefore, 
we found the BCW to be a systematic and comprehensive theory enabling us to clearly 
outline which intervention affects a specific behaviour. 
Limitations of this study include that we have tailored it specifically to the local setting and it 
may not be generalizable to other setting. Another criticism is that the area of intervention is 
complex and the constructs may still be too ill-defined to be able to establish useful, 
scientifically based evidence. The authors of the BCW also note that no framework can 
address the level of detail required to determine what will or will not be an effective 
intervention.  However, they suggest that these are empirical questions and there is already 
evidence that character intervention by BCT can aid in the understanding and identifying 
which intervention are more or less effective (59, 46, 60).  
 
Conclusion 
In conclusion, based on the BCW we have systematically identified four intervention 
(environment restructuring, education, persuasion, enablement) components to develop an 
acceptable, practical and sustainable osteoporosis programme. 
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